Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Cancer Type/Condition:  Colon cancer
Trial Type:  Prevention
Trial Status:  Active
Results 1-21 of 21 for your search:
Start Over
The Effects of Vitamin B-6 Status on Homocysteine, Oxidative Stress, One-carbon Metabolism and Methylation: Cross-section, Case-control, Intervention and Follow-up Studies in Colorectal Cancer
Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: S10251, NCT01426490
Study of Folic Acid, Calcium and Vitamin D in Preventing Colorectal Polyps and Colorectal Cancer
Phase: Phase III, Phase II
Type: Prevention
Status: Active
Age: 50 to 80
Sponsor: Other
Protocol IDs: SQ2011SF12RJ, SQ2011SF12-20121010, NCT02066688
S0820, Adenoma and Second Primary Prevention Trial
Phase: Phase III
Type: Prevention
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: S0820, U10CA037429, NCI-2012-02067, NCT01349881
Trial of Eflornithine Plus Sulindac in Patients With Familial Adenomatous Polyposis (FAP)
Phase: Phase III
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: Not specified
Sponsor: Pharmaceutical / Industry
Protocol IDs: CPP-FAP-310, NCT01483144
Acetylsalicylic Acid and Colorectal Cancer Prevention: Exploring the Platelet Function of Its Mechanism of Action
Phase: Phase III
Type: Biomarker/Laboratory analysis, Prevention
Status: Approved-not yet active
Age: 18 to 69
Sponsor: Other
Protocol IDs: D-13-01, 2013-004269-15, NCT02125409
Influence of Sulindac and Probiotics on the Development of Pouch Adenomas in Patients With Familial Adenomatous Polyposis
Phase: Phase II
Type: Prevention
Status: Active
Age: 16 and over
Sponsor: Other
Protocol IDs: 23266, KUN 2003-2911, NCT00319007
Acetylsalicylic Acid and Eflornithine in Treating Patients at High Risk for Colorectal Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology, Prevention
Status: Active
Age: 40 to 120
Sponsor: NCI
Protocol IDs: NCI-2009-01192, 09-001758, MC054A, R01-CA-113681, P30CA015083, NCT00983580
Minimizing the Risk of Metachronous Adenomas of the Colorectum With Green Tea Extract -MIRACLE-
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 50 to 80
Sponsor: Other
Protocol IDs: MIRACLE, NCT01360320
Fish Oil Supplementation, Nutrigenomics and Colorectal Cancer Prevention
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 40 to 79
Sponsor: NCI, Other
Protocol IDs: 11165, R01CA160938, NCT01661764
Chemopreventive Action of Mesalazine on Colorectal Cancer: a Pilot Study for an "in Vivo" Evaluation of the Molecular Effects on ß-catenin Signaling Pathway.
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: MES-CT 01, NCT02077777
Latino Peers as Patient Navigators for Colon Cancer Screening
Phase: Phase II
Type: Prevention
Status: Active
Age: 50 and over
Sponsor: Other
Protocol IDs: GCO 11-1374, NCT02226107
Curcumin in Preventing Colorectal Cancer in Patients Undergoing Colorectal Endoscopy or Colorectal Surgery
Phase: Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000648267, LRI-UL-CURCUMIN, EUDRACT-2007-001971-13, EU-20961, UL-CURCUMIN, NCT00973869
Trial of Linaclotide to Demonstrate Colorectal Bioactivity in Health Volunteers
Phase: Phase I
Type: Prevention
Status: Approved-not yet active
Age: 18 to 65
Sponsor: NCI, Other
Protocol IDs: MAY2012-00-01, HHSN261201200032I, 13-829, NCT01912079
Naproxen in Preventing DNA Mismatch Repair Deficient Colorectal Cancer in Patients With Lynch Syndrome
Phase: Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2014-00046, HHSN261201200034I, HHSN26100003; RFP B, MDACC-2013-0698, N01-CN-2012-00034, 2013-0698, MDA2013-01-02, N01CN00034, P30CA016672, NCT02052908
Berberine Chloride in Treating Patients With Ulcerative Colitis in Remission
Phase: Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Approved-not yet active
Age: 18 to 70
Sponsor: NCI
Protocol IDs: NCI-2015-00173, NCI 2014-03-01, NWU2014-03-01, N01CN00035, P30CA060553, NCT02365480
Personalized Prevention of Colorectal Cancer Trial
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 40 to 85
Sponsor: Other
Protocol IDs: 100106, NCT01105169
Colon Cancer Prevention Using Selenium
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention
Status: Approved-not yet active
Age: 50 and over
Sponsor: Other
Protocol IDs: 2008-1122, NCT01211561
Cruciferous Vegetable Intake and Histone Status in Screening Colonoscopy Patients
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention, Screening
Status: Active
Age: 50 to 75
Sponsor: NCI, Other
Protocol IDs: P01 CA090890, NCT01344330
FlaxFx, A Research Study of the Effects of Flaxseed Lignans on Colon Health
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 20 to 45
Sponsor: NCI, Other
Protocol IDs: FHCRC IR 7532, NCT01619020
Effects of Eicosapentaenoic Acid on Subjects at High Risk for Colorectal Cancer
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: EPAUC/2013, NCT02069561
ASPirin Intervention for the REDuction of Colorectal Cancer Risk
Phase: No phase specified
Type: Prevention
Status: Approved-not yet active
Age: 18 to 80
Sponsor: NCI, Other
Protocol IDs: 14-496, R01CA137178, NCT02394769
Start Over